ZANGRANDO, ANDREA

ZANGRANDO, ANDREA  

Mostra records
Risultati 1 - 6 di 6 (tempo di esecuzione: 0.007 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Gene expression-based classification as an independent predictor of clinical outcome in juvenile myelomonocytic leukemia. 2010 BRESOLIN, SILVIATRENTIN, LUCAZANGRANDO, ANDREASAINATI, LAURATE KRONNIE, GEERTRUDYBASSO, GIUSEPPE + JOURNAL OF CLINICAL ONCOLOGY - -
An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer. 2015 Agostini, MarcoD'ANGELO, EDOARDOZANGRANDO, ANDREADIGITO, MAURABORTOLUZZI, STEFANIANITTI, DONATOPUCCIARELLI, SALVATORE + ONCOTARGET - -
Acute Lymphoid Leukaemias (ALL) and Minimal Residual Disease in ALL 2018 Basso GiuseppeBuldini BarbaraZangrando Andrea - - Multiparameter Flow Cytometry in the Diagnosis of Hematologic Malignancies
Cerebrospinal fluid analysis by 8-color flow cytometry in children with acute lymphoblastic leukemia 2019 GABELLI, MARIADISARO', SILVIAScarparo, PamelaFrancescato, SamuelaZangrando, AndreaBasso, GiuseppeBuldini, Barbara + LEUKEMIA & LYMPHOMA - -
Relative expansion of CD19-negative very-early normal B-cell precursors in children with acute lymphoblastic leukaemia after CD19 targeting by blinatumomab and CAR-T cell therapy: implications for flow cytometric detection of minimal residual disease 2021 Zangrando A.Buldini B. + BRITISH JOURNAL OF HAEMATOLOGY - -
CD56, HLA-DR, and CD45 recognize a subtype of childhood AML harboring CBFA2T3-GLIS2 fusion transcript 2021 Zangrando A.Cavagnero F.Scarparo P.Francescato S.Tregnago C.Fagioli F.Santoro N.Pigazzi M.Basso G.Buldini B. + CYTOMETRY. PART A - -